BATES WESTON AUDIT LIMITED

Financial Health Score: B+

Explanation: The patient is exhibiting a strong, encouraging recovery after a severe period of financial illness between 2020 and 2023, which saw net assets plummet from over £2.1m to a worrying low of £403k. The latest results for 2025 show the business responding well to treatment: retained earnings are up significantly, cash reserves are healthy, and long-term liabilities are being paid down. While the company is not yet back to its peak historical condition, its current trajectory and liquidity position indicate a robust convalescence.

Key Vital Signs

• Pulse (Liquidity & Cash Flow): Strong and Steady. Cash at bank has surged by 37% from £402,730 in 2024 to £552,718 in 2025. The current ratio (current assets vs. current liabilities) sits at a highly healthy 1.88:1, meaning the business has nearly £2 of short-term assets for every £1 of short-term debt. The patient's blood flow is unrestricted.
• Blood Pressure (Leverage & Debt): Improving, but Requires Monitoring. Long-term liabilities have been reduced from £1.03m to £811k—a significant drop of over £220k. However, total liabilities still sit at £811k against net assets of £815k. The debt pressure is easing, but the balance sheet is still moderately leveraged due to the lingering "other creditors" of £720k owed after more than one year.
• Weight (Net Assets & Retained Earnings): Gaining Healthy Mass. Net assets have grown from £577k to £815k, an increase of £238k. This is driven directly by a jump in retained earnings (from £458k to £696k), proving the business is currently profitable and retaining its strength rather than bleeding resources.
• Stamina (Operational Efficiency): Good. The average number of employees increased slightly from 73 to 76, alongside the increase in retained earnings. This suggests the firm is generating more profit per head or utilizing its team more effectively to drive bottom-line recovery.

Diagnosis

Condition: Post-Traumatic Financial Recovery with Underlying Related-Party Complexities

Between 2020 and 2023, BATES WESTON AUDIT LIMITED suffered from acute financial atrophy, with its net assets dropping by over £1.7 million. In a medical context, this would be akin to a severe, lingering illness that depleted the patient's reserves. In a financial context, this was almost certainly caused by significant distributions to shareholders (likely the parent LLP or partners), trading losses, or writing off bad debts.

However, the 2024 and 2025 data reveal that the patient has turned a critical corner. The business is generating healthy cash, retaining its profits, and actively paying down long-term debts. The "infection" that caused the equity drain appears to have been treated.

A notable anatomical feature of this patient is the £950,000 fixed asset investment in an LLP (likely the associated Bates Weston partnership) and £840,000 (now £720,000) owed to "other creditors" long-term. These related-party vital signs mean the audit limited company's health is intrinsically tied to the health of the wider partnership group. While the limited company's own heartbeat is currently strong, any distress in the LLP could quickly transmit through these financial pathways.

Recommendations

1. Continue the Debt Reduction Regimen: The reduction of long-term creditors by £220k this year is an excellent sign. Continue prioritizing the repayment of the £720k owed to "other creditors" to further lower blood pressure and reduce reliance on external/related party funding.
2. Build Up the Immune System (Cash Buffers): While cash is currently strong, the trauma of the 2020-2023 period shows how quickly reserves can be depleted. Maintaining a minimum cash reserve of £500k (which they have just achieved) will act as an immune booster against future economic shocks.
3. Monitor Related-Party Exposures: Given the significant LLP investment and inter-company balances, implement regular "check-ups" to ensure the wider group's financial health remains stable. Any cash calls or distributions from the LLP should be carefully managed to avoid re-injuring the limited company's balance sheet.
4. Maintain Profitability Focus: The £238k boost to retained earnings is the lifeblood of the current recovery. Avoid aggressive dividend distributions until net assets return to pre-2020 levels (circa £1.6m-£2m) to ensure the patient is fully rehabilitated.